Tampilkan postingan dengan label News. Tampilkan semua postingan
Tampilkan postingan dengan label News. Tampilkan semua postingan

Rabu, 26 Maret 2014

Hepatitis C drug Sovaldi is priced $1000 per pill, $84,000 per Course!


The U.S. lawmakers have inquired Gilead Chief Executive John C. Martin about the high cost of its new Hepatitis C drug Sovaldi, which is priced $1000 per pill, $84,000 per course!
Gilead Sciences, a biotechnology company has manufactured a new drug called “Sovaldi” for Hepatitis C. According to the company, the drug will cost $1000 per pill, so the amount of pills required for a complete course

Senin, 24 Maret 2014

No Makeup Selfie Trend goes Viral to raise £1M for cancer charity


Help!!! Recently, women across the UK follow unusual trend of posting 'no makeup' selfies that notably help to raise cancer awareness and donations. Know about this viral trend in details, here.

Social media is mostly talk of the town, sometimes for its hitches and sometimes for its goodness. This time in UK, Social media timelines have been covered up with ‘no make-up selfie’ trend, where

Rabu, 30 Oktober 2013

Hepatitis C drug Gilead's sofosbuvir to get FDA Approval


Check out the positive review of Gilead Sciences Inc's hepatitis C drug - Sofosbuvir given by the ‘U.S. Food and Drug Administration’ (FDA).

Gilead Sciences’ much-anticipated hepatitis C drug, named as Sofosbuvir, has been given the thumbs up by an FDA advisory group. All 15 members of the Food and Drug Administration’s panel of virus experts have voted in favor of approving Sofosbuvir, a daily